Particulate pollution, also called particle pollution or particulate matter (PM), is a mixture of solid particles and liquid droplets in the air. Particles come in many sizes and shapes and can be made up of hundreds of different chemicals.
Particulate matter is classified by size. “Fine particles,” or PM2.5, are those smaller than 2.5μm (micrometers, or microns), in diameter, which is about 30 times smaller than the diameter of an average human hair. Coarse particles, or PM10, are between 2.5 and 10μm in diameter. Smaller than PM2.5 are ultrafine particles, PM0.1.
Particles larger than PM10 do not go into the deepest parts of the lungs, and they can be coughed out. Particles smaller than PM10, however, are inhaled into the deepest parts of the lungs, where they become embedded and can cause disease. The smallest ultrafine particles, which are numerous in wood smoke, are so minute they behave like gases, passing through the lungs and directly into the bloodstream.
Once in the bloodstream, these ultrafine particles carry toxins around the body and promote inflammation.
Ultrafine particles also travel up through the nose and, rather than passing down into the lungs, are delivered directly into the brain and central nervous system via the olfactory nerve, bypassing the body’s protective blood/brain barrier.
Numerous peer-reviewed studies have described the adverse health effects, including premature death, that are associated with particulate pollution. Effects have been observed at levels as low as 10–20 μg/m3 of PM10, which are levels equal to or below background in many parts of the world. Many studies have shown no evidence of a threshold — an amount under which exposure does not harm health.
Increases in particulate pollution levels can trigger heart attacks, strokes and irregular heart rhythms, especially in those with preexisting heart or lung diseases, and aggravate other lung diseases such as asthma and COPD.
in the Lancet found a close and consistent association between short-term exposure to ambient air pollution levels and acute decompensated heart failure and heart failure deaths. The authors estimated that, in the US alone, a mean reduction in PM2.5 of only 3.9 μg/m3 would prevent 7,978 heart failure hospitalizations and save a third of a billion dollars a year.
A 2015 study of New England Medicare recipients over age 65 determined that the death rate rises for each 10μg/m3 increase in PM2.5, both from short-term and long-term exposure, and even when pollution levels do not exceed US EPA or World Health Organization thresholds.
These findings were consistent with those of several other studies that have also found an association between particulate pollution levels and an increase in the mortality rate, even at levels that are considered low by regulatory standards.
Joel Schwartz, senior author of the New England study and professor of environmental epidemiology at Harvard T.H. Chan School of Public Health, this was the first study to examine the effect of airborne soot particles over an entire region, including rural areas.
“The harmful effects from the particles were observed even in areas where concentrations were less than a third of the current standard set by the EPA.” According to Schwartz, “Particulate pollution is like lead pollution; there is no evidence of a safe threshold even at levels far below current standards, including in the rural areas we investigated.”
More recently, Schwartz and other researchers at Harvard looked at data covering 60 million U.S. seniors. Thiswhich covered approximately 97% of U.S. residents aged 65 and older, similarly found that long-term exposure to PM2.5 increases the risk of premature death, even at levels below current regulatory standards.
In 2013, the WHO’s specialized cancer agency, the International Agency for Research on Cancer (IARC), outdoor air pollution and particulate matter as carcinogenic. They also reaffirmed that “long-term exposure to PM2.5 can trigger a range of problems, such as atherosclerosis, adverse birth outcomes and childhood respiratory diseases.”
Research has that long-term exposure to even slightly elevated PM2.5 levels is associated with a .32% smaller total brain volume and a 46% higher risk of silent strokes, even in people who haven’t yet developed dementia or had obvious strokes.
Long-term exposure to elevations in particulate levels is with increased first-time hospital admissions for Parkinson’s disease, Alzheimer’s disease and dementia. The risk was seen even at relatively low levels of pollution.
A found that older women residing in places with fine particulate matter exceeding EPA standards had an 81% increased risk of global cognitive decline, and were 92% more likely to develop dementia from any cause, including Alzheimer's. The risk was even stronger in women who had the APOE4 gene, a genetic variation that increases the risk for Alzheimer's.
Another has also linked fine particulate pollution with worsened cognitive function. It was found that episodic memory is most impaired by exposure to PM2.5. “Episodic memory impairment is one of the core diagnostic criteria used to determine mild cognitive impairment and dementia in older adults, and it has been suggested that impairments in this aspect of memory represent some of the earliest signs of dementia.”
It was noted that particulates can affect the respiratory and cardiovascular systems, which can in turn affect the vascular pathology in the brain. Particulates may even directly damage the brain itself. “Studies of both humans and animals have confirmed that exposure to PM is linked to harmful changes in brain health and functioning.”
Other studies have also confirmed an association between cognitive decline and long-term exposure to particulate pollution. For example, it that exposure to particulate pollution at levels “typically experienced by many individuals in the United States is associated with significantly worse cognitive decline in older women.”